Advertisement

Questions 1–10

  • Yousaf Ali
Chapter

Abstract

This chapter illustrates a variety of different scenarios of rheumatic disease in succinct question and answer format. It contains ten complex cases with potentially unusual diagnoses designed to stimulate thought and further reading in this rapidly evolving specialty.

Keywords

Assessment of rheumatic diseases Complex rheumatology cases Rare rheumatic diseases Rheumatology board exam preparation Rheumatology case studies Study guide for rheumatology 

References

  1. 1.
    Keller EC, Tomecki KJ, Alraies MC. Distinguishing cellulitis from its mimics. Cleve Clin J Med. 2012;79(8):547–52.CrossRefPubMedGoogle Scholar
  2. 2.
    Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315(22):2442–58.CrossRefPubMedGoogle Scholar
  3. 3.
    Rudwaleit M, Taylor WJ. Classification criteria for psoriatic arthritis and ankylosing spondylitis/axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2010;24(5):589–604.CrossRefPubMedGoogle Scholar
  4. 4.
    Moore L. Parvovirus-associated arthritis. Curr Opin Rheumatol. 2000;12(4):289–94.CrossRefPubMedGoogle Scholar
  5. 5.
    Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–38.CrossRefPubMedGoogle Scholar
  6. 6.
    Khawaja AZ, Cassidy DB, Shakarchi JA, McGrogan DG, Inston NG, Jones RG. Revisiting the risks of MRI with gadolinium based contrast agents—review of literature and guidelines. Jones Insights Imag. 2015;6(5):553–8.CrossRefGoogle Scholar
  7. 7.
    High WA, Ayers RA, Chandler J, et al. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol. 2007;56(1):21–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Blake T, Manahan M, Rodins K. Erythema nodosum – a review of an uncommon panniculitis. Dermatol Online. 2014;20(4):22376.Google Scholar
  9. 9.
    Gettler S, Rothe M, Grin C, Grant-Kels J. Optimal treatment of pyoderma gangrenosum. Am J Clin Dermatol. 2003;4(9):597–608.CrossRefPubMedGoogle Scholar
  10. 10.
    Ingegnoli F, Smith V, Sulli A, Cutolo M. Capillaroscopy in routine diagnostics: potentials and limitations. Curr Rheumatol Rev. 2018;14(1):5–11.  https://doi.org/10.2174/1573397113666170615084229.CrossRefPubMedGoogle Scholar
  11. 11.
    Micheletti RG, Werth VP. Small vessel vasculitis of the skin. Rheum Dis Clin N Am. 2015;41(1):21–32. viiCrossRefGoogle Scholar
  12. 12.
    Baraf SB, Becker MA, Gutierrez-Urena SR, et al. Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy Herbert. Arthritis Res Ther. 2013;15(5):R137.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Bleyer AJ, Wright D, Alcorn H. Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis. Clin Nephrol. 2015;83(5):286–92.CrossRefPubMedGoogle Scholar
  14. 14.
    Rao DA, Dellaripa PF. Extrapulmonary manifestations of sarcoidosis. Rheum Dis Clin N Am. 2013;39(2):277–97.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Yousaf Ali
    • 1
  1. 1.Mount Sinai HospitalNew YorkUSA

Personalised recommendations